COPD Flashcards

1
Q

COPD

A

chronic, obstructive pulmonary disease that is characterized by airflow limitation that is not fully reversible and progressive, associated with abnormal inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Two subtypes of COPD

A

Chronic bronchitis and emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic bronchitis

A

cough and sputum production for at least 3 months of two consecutive years in absence of other bronchial disease; chronic cough, increased mucous, SOB, throat clearing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Emphysema

A

over inflation of distal airspaces with destruction of aveolar sacs and loss of stretch and recoil, trapped air worsens oxygenation; cough, SOB, limited exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors of COPD

A

smoking, occupation, environment, air pollution, nutrition, infection, socio-economic status, age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anticholinergic long acting

A

umeclindiniu, (incruse), Aclidinium (tudorza), Tiotropium (Spiriva)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anticholinergic short acting

A

Ipratropium (Atrovent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Long acting B agonists

A

Salmeterol (Serevent), Formoterol (Foradil), Aformoterol (Brovana), INdacaterol (Arcapta), Vilanterol (only in combo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Short acting B agonists

A

Albuterol (Proventil), Levalbuterol (Xopenex), Terbutalin (Brethine), Pirbuterol (Maxair)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inhaled corticosteroids

A

Beclomethasone (Qvar), Budesonide (Pulmicort), Flunisolide (Aerospan), Fluticasone (Flovent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Combined Products

A

Ipratropium/Albuterol, Fluticasone/salmeterol (Advair), Budesonide/Formoterol (Symbicort)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ADRs of COPD drugs

A

Very little concern because drug is inhaled and goes straight to the source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bronchodilator highlights

A

short and long acting B2 agonist, anticholinergic agents, Methyxanthine-theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Primary use of bronchodilators

A

symptomatic relief of SOB, may not increase exercise tolerance or improve FEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

B2 agonist bronchdilators MOA

A

Agonist at B2 receptor catalyzing ATP conversion to cAMP resulting in bronchial smooth muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Albuterol Pearls

A

DOC for rescue, always use albuterol first if using other inhalers, tachy most notable with high doses, tablets and syrups available, some therapy for hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ADR of LABA

A

headache, arthralgia, tremor, anxiety, palpitations, diarrhea, nausea, insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

LABA Pearls

A

Not for emergency, long duration and onset, used in combo with ICS or anticholinergics, may use in addition to albuterol,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the only LABA approved for COPD instead of asthma?

A

Aformoterol (Brovana)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Risks with LABA monotherapy

A

increased overall death, but not when used with corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anticholinergic Bronchodilators MOA

A

Inhibition of acetylcholine at muscarinic receptors resultin in bronchodilation, decreases respiratory secretions

22
Q

Short acting anticholinergic bronchodilators

A

Ipratropium (atrovent)

23
Q

Long Acting anticholinergic bronchodilators

A

Tiotropium (Spiriva), Umeclidinium (incruse), Aclidinium (Tudorza)

24
Q

Pearls of anticholinergic bronchodilators

A

Ipratropium DOC for inpt use, combo with albuterol, niche with asthma indication; longer duration, longer onset, restrictive price tag

25
Q

Ipratropium (atrovent) pearls

A

give multiple doses per day, combo for ease of administration, decrease cost

26
Q

Tiotropium (Spiriva)

A

Increased cost, long duration, once daily, decreased exacerbation, given in conjunction w/ LABA +/- ICS, can be used as mono therapy

27
Q

Theophylline (Theo dur) MOA

A

methylxanthine, PDE I, increases cAMP causes bronchodilator effect, less effective and tolerated than LABA

28
Q

Theophylline (Theo dur) ADR

A

tachy, HA, insomnia, restlessness, GI intolerance

29
Q

Theophylline (Theo dur) clinical use

A

primarily considered when pt cannot tolerate inhaled bronchodilators or have maxed out inhaled therapies, coupled with LABA to improve FEV

30
Q

Inhaled corticosteroids MOA

A

anti-inflammatory, immunosuppressive, antiproliferative

31
Q

Long term ICS use

A

only appropriate for symptomatic COPD pts w/ an FEV

32
Q

ADRs of ICS

A

Oral thrush, patients should always wash/rinse mouth after dose, HA, upper respiratory tract infection

33
Q

ICS drug type

A

Fluticasone (Flovent), Budesonide (pulmicort), Mometasone (Asmanex)

34
Q

ICS Pearls

A

usually combo, unfavorable benefit-to-risk ratio, short term improvement

35
Q

Combination products

A

ipratropium/ albuterol, salmeterol/ fluticasone (advair), Formoterol/ Budesonide (symbicort)

36
Q

Combo products

A

in absence of cost restriction these are most commonly used agents and way of future!

37
Q

Roflumilast (Daliresp)

A

PDE-I, treat sever to very severe, reduces exacerbations treated with ICS, LABA, only PO, ADR: poor appetite, N/V. diarrhea, do not give with theophylline

38
Q

Expectorants and mucollytics

A

Best option? acetylcysteine (Mucomyst), gaifenesin (mucinex)

39
Q

Antibiotics for COPD

A

severe exacerbations

40
Q

Non pharm options for COPD

A

pulm rehab, o2 therapy (stage 4), surgical intervention

41
Q

Guaifenesin (Mucinex)

A

mucolytic, cough expectorant, tablet and liquid, no ADRs or DI, take w/ lot of H2O

42
Q

Primary treatment goals of COPD

A

Relieve symptoms, prevent progression, improve exercise tolerance, improve health status, prevent complications, reduce mortality/SE

43
Q

Treatment of Mild COPD

A

active reduction of risk factors, vaccinations, Shortacting bronchodilators

44
Q

Treatment of moderate COPD

A

regular treatment with long-acting bronchodilators, pulm rehab

45
Q

Treatment of severe COPD

A

inhaled corticosteroids

46
Q

Treatment of very severe COPD

A

long term O2, systemic steroids, surgery

47
Q

Prevention and risk factor reduction

A

smoking cessation, influenza and pneumonococcal vaccine, pulmonary rehab

48
Q

5 A’s of smoking cessation

A

Ask, advise, assess, assist, arrange

49
Q

Smoking cessation options

A

gum, inhaler, nasal spray, transdermal patch, sublingual tablet, lozenge, prescription, E cigs

50
Q

Smoking cessation drugs

A

Varenicline (Chantix), Buproprion (Welbutrin, Zyban), Nortriptylline

51
Q

Treatment of COPD exacerbations

A

Bronchodilators (SABA DOC, anticholinergic), Corticosteroids, O2, mechanical ventilation, antibiotics controversial

52
Q

Must have following symptoms for antibiotic therapy

A

increased dyspnea, sputum volume, and sputum purulence